Atea Pharmaceuticals, Inc. (AVIR) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $39.78M | +54.2% |
| 2024 | $25.80M | -35.1% |
| 2023 | $39.78M | +52.2% |
| 2022 | $26.14M | -58.4% |
| 2021 | $62.81M | -80.1% |
| 2020 | $315.83M | +12383.4% |
| 2019 | $2.53M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $39.78M | +54.2% |
| 2024 | $25.80M | -35.1% |
| 2023 | $39.78M | +52.2% |
| 2022 | $26.14M | -58.4% |
| 2021 | $62.81M | -80.1% |
| 2020 | $315.83M | +12383.4% |
| 2019 | $2.53M | — |